BioAge Labs to Present at Upcoming Investor Conferences

About this update from Bioage Labs, Inc.

[{"type":"image","alt":"BioAge Labs, Inc.","displaySize":"","headline":null,"caption":"BioAge Labs, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/612cb01db2ea44f61d54947f4e4723e0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5Q4VL90BcRUw5eG_L017gw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/612cb01db2ea44f61d54947f4e4723e0","width":300,"height":300}},"lazy":false},{"type":"text","content":"EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:","length":376,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Citi’s 2025 Biopharma Back to School Conference (Boston, September 2–3, 2025): Kristen Fortney, PhD, CEO and co-founder, and Dov Goldstein, MD, CFO, are scheduled to participate in a fireside chat on Wednesday, September 3 at 3:15–3:55 PM EDT, and will participate in one-on-one meetings. To access the live webcast of the presentation, register here.","length":351,"tagName":"p"}]},{"val":[{"type":"text","content":"Morgan Stanley 23rd Annual Global Healthcare Conference (New York, September 8–10, 2025): Kristen Fortney, PhD, CEO and co-founder, and Dov Goldstein, MD, CFO, are scheduled to participate in a fireside chat on Wednesday, September 10 at 10:00–10:45 AM EDT, and will participate in one-on-one meetings. To access the live webcast of the presentation, register here.","length":365,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":716,"olType":false},{"type":"text","content":"Replays of the webcasts will be available in the investor section of the company's website at https://ir.bioagelabs.com/, and will be archived for 30 days following the presentations.","length":187,"tagName":"p"},{"type":"text","content":"About BioAge Labs, Inc.","length":23,"tagName":"p"},{"type":"text","content":"BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human ag...

More updates from Bioage Labs, Inc.